Ingalls & Snyder LLC Novo Nordisk A S Transaction History

Ingalls & Snyder LLC

  • $2.55 Billion
  • Q4 2024

A detailed history of Ingalls & Snyder LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ingalls & Snyder LLC holds 52,646 shares of NVO stock, worth $4.42 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
52,646
Previous 51,685 1.86%
Holding current value
$4.42 Million
Previous $6.15 Million 26.41%
% of portfolio
0.18%
Previous 0.24%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
BUY
$85.0 - $120.04 $81,685 - $115,358
961 Added 1.86%
52,646 $4.53 Million
Q3 2024

Nov 14, 2024
BUY
$119.07 - $145.42 $123,475 - $150,800
1,037 Added 2.05%
51,685 $6.15 Million
Q2 2024

Jul 31, 2024
BUY
$122.71 - $146.91 $2.43 Million - $2.91 Million
19,839 Added 64.39%
50,648 $7.23 Million
Q1 2024

May 13, 2024
SELL
$102.11 - $135.92 $240,469 - $320,091
-2,355 Reduced 7.1%
30,809 $3.96 Million
Q4 2023

Jan 29, 2024
SELL
$87.78 - $105.45 $155,809 - $187,173
-1,775 Reduced 5.08%
33,164 $3.43 Million
Q3 2023

Nov 02, 2023
BUY
$90.94 - $199.54 $1.59 Million - $3.49 Million
17,471 Added 100.02%
34,939 $3.18 Million
Q3 2021

Oct 27, 2021
SELL
$84.42 - $106.62 $166,729 - $210,574
-1,975 Reduced 10.16%
17,468 $1.68 Million
Q2 2021

Aug 03, 2021
SELL
$67.66 - $84.76 $1,691 - $2,119
-25 Reduced 0.13%
19,443 $1.63 Million
Q4 2020

Jan 27, 2021
SELL
$63.89 - $73.8 $63,890 - $73,800
-1,000 Reduced 4.89%
19,468 $1.36 Million
Q3 2020

Oct 21, 2020
SELL
$63.69 - $70.22 $70,059 - $77,242
-1,100 Reduced 5.1%
20,468 $1.42 Million
Q2 2020

Jul 31, 2020
SELL
$58.54 - $67.94 $43,905 - $50,955
-750 Reduced 3.36%
21,568 $1.41 Million
Q4 2019

Jan 15, 2020
BUY
$49.86 - $58.26 $177,750 - $207,696
3,565 Added 19.01%
22,318 $1.29 Million
Q3 2019

Oct 16, 2019
SELL
$47.54 - $53.43 $23,912 - $26,875
-503 Reduced 2.61%
18,753 $970,000
Q2 2019

Jul 11, 2019
SELL
$46.79 - $52.47 $228,803 - $256,578
-4,890 Reduced 20.25%
19,256 $983,000
Q1 2019

Apr 11, 2019
SELL
$46.36 - $52.63 $1.56 Million - $1.77 Million
-33,588 Reduced 58.18%
24,146 $1.26 Million
Q4 2018

Jan 24, 2019
SELL
$41.54 - $47.25 $1.21 Million - $1.38 Million
-29,192 Reduced 33.58%
57,734 $2.66 Million
Q3 2018

Oct 24, 2018
BUY
$46.76 - $51.24 $4.06 Million - $4.45 Million
86,926 New
86,926 $4.1 Million

Others Institutions Holding NVO

# of Institutions
1,879
Shares Held
317M
Call Options Held
5.49M
Put Options Held
7.77M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $190B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email